Tobias Tovedal, a UBI business coach, becomes CEO of Patient Safety Surveillance Solutions (P3S), a KI startup developing software for monitoring healthcare-associated injuries. His leadership aims to enhance patient safety through real-time data analysis and expansion to more hospitals in Sweden.
Umeå Biotech Incubator has been awarded SEK 14.6 million in excellence funding by Vinnova, reaffirming its status as an excellent incubator. This funding, designated for 2025-2029, supports startups' growth, emphasizing sustainability and gender equality in business development.
HILICON, based in Umeå, has achieved record turnover and significant market presence in chromatography within ten years. CEO Wen Jiang aims to launch new products in 2025, expand the premises, and in the long term double the turnover while maintaining a focus on innovation and tailored customer solutions.
MetaCurUm AB has received a SEK 1 million grant from the Swedish Innovation Agency Vinnova to advance its therapeutic antibody for prostate cancer toward clinical trials. The Vinnova funds will be used further to validate MetaCurUm's mechanism of action and product. MetaCurUm is collaborating with the Institute of Cancer Research in London and Professor Johan de Bono.
Four pilot projects will receive dedicated support to accelerate the commercialization of their specific biological product through BRIDGE Sweden. The projects, three Academic and one start-up, will set the standard, help to identify essential offerings and refine the approach at SciLife Lab’s DDD platform, Testa Center and Lund’s Stem Cell Center and pre-GMP facility.
The Moss Man, Daniel Pacurar of Boreal Orchards will present his re:moss concept to global leaders at UNCCD COP16 in Saudi Arabia. The conference aims to combat drought and desertification. It unites global leaders focused on ecological restoration, emphasizing international collaboration for a sustainable future. Daniel Pacurar receives business support by Umeå Biotech Incubator.
Medicvent, based in Umeå, is seeking a new CEO as Erik Lindström transitions to a role within parent company Sdiptech. Founded in 1983, Medicvent focuses on air pollutant evacuation solutions for healthcare and plans to continue to expand internationally.
The Swedish MedTech company Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC). Mucocort develops a mucoadhesive "patch" for mouth ulcers (aphthous stomatitis), one of the most common oral mucosal diseases.
Sofia Mayans, a seasoned life science professional and co-founder of InfiCure Bio, has joined Diamyd Medical in Umeå as Director of Business Development, focusing on leveraging new production capabilities and exploring additional business opportunities related to diabetes treatment.
QureTech Bio has secured a SEK 14 million investment from Kempestiftelserna and Nascent Invest to enhance its development of innovative antibiotics targeting antimicrobial resistance. The funding will accelerate programs addressing multidrug-resistant bacteria, significantly impacting global health advancements.
Urban Eriksson has been appointed Chairman of Umeå Biotech Incubator, bringing 30 years of leadership experience, notably as CEO of SLU Holding. He emphasizes the importance of bridging research and practical applications in life sciences for sustainable development.
Umeå based Nil Medical has developed an ergonomic, medical vest for children undergoing cancer treatment, allowing for greater mobility by concealing IV equipment within the garment. The vest is being evaluated in a national quality of life study, in collaboration with Swedish healthcare. Nil Medical aims to introduce the CE-marked "Vestpack" to the international market.
AlexoTech, a Swedish biotech firm, achieved a record turnover in 2023, driven by strong demand for customized proteins and peptides. CEO Anders Olofsson emphasizes sustainable growth, inspired by local role model Agrisera, and plans to expand workforce and product offerings. AlexoTech is based in Umeå, a rapidly growing life science city.
Umeå based QureTech Bio has appointed Markus Thor as CEO, succeeding Helén Fält. With 30 years of pharmaceutical experience, Thor aims to advance the life science company's pipeline toward clinical trials, focusing on solutions for antimicrobial resistance.
Christian Hedberg, a professor at Umeå University, is developing a revolutionary drug to treat cryptosporidiosis in animals and humans. He collaborates with France's INRAE and the treatment has shown promising results in ruminant models and has the potential to address a significant global health issue. Christian Hedberg has joined Umeå Biotech Incubator to bring the treatment to the market.
HiloProbe, based in Umeå, secures SEK 3 million in funding from existing owners for sales initiation. The capital injection aims to attract more investment and reach a break-even point. The company is close to a breakthrough with ColoNode, a reagent kit for analyzing lymph nodes in colorectal cancer patients.
Umeå secures 1.8 million (22 SEK million) in EU funding for life science projects to boost innovation and industry growth. The project "Life Science City" is run by Umeå Biotech Incubator and seeks to expand the sector and strengthen collaborations. The SOLH project is a joint effort between Västerbotten and Norrbotten aiming to streamline and unify the innovation system.
MetaCurUm Biotech AB plans to raise 100 million SEK following founder Maréne Landström being named Sweden's Cancer Researcher of the Year. Their groundbreaking cancer treatment, still in the preclinical phase, aims to halt the TGFβ pathway cancer cells utilize. The Umeå based company is collaborating with international researchers and exploring biomarkers for patient stratification.
Mucocort AB has received approval to start a clinical trial for an intraoral patch (M045A) to treat aphthous stomatitis, a condition causing mouth ulcers. The patch aims for immediate pain relief and healing promotion. The trial will be conducted in collaboration with Oral Care AB and produced by Aurena Laboratories AB in Sweden.
The Umeå company SpinChem has joined the Enzyme Technology Alliance, a group of six European companies collaborating to bring competitive solutions to the biotech industry. CEO Emil Byström states the alliance can offer solutions unimaginable before, aiming to replace harmful processes with environmentally friendly alternatives and contribute to a more sustainable industry.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden